Synthesis and evaluation of fluorescent Pam3Cys peptide conjugates.

[1]  I. Toth,et al.  Investigation of Structure–Activity Relationships of Synthetic Anti‐Gonadotropin Releasing Hormone Vaccine Candidates , 2015, ChemMedChem.

[2]  Jinbo Li,et al.  Development of Bioorthogonal Reactions and Their Applications in Bioconjugation , 2015, Molecules.

[3]  D. Filippov,et al.  Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates , 2014, Cancer Immunology Research.

[4]  Yingkai Zhang,et al.  Site-specific incorporation of three toll-like receptor 2 targeting adjuvants into semisynthetic, molecularly defined nanoparticles: application to group a streptococcal vaccines. , 2014, Bioconjugate chemistry.

[5]  J. V. van Hest,et al.  Bioorthogonal labelling of biomolecules: new functional handles and ligation methods. , 2013, Organic & biomolecular chemistry.

[6]  N. Shakya,et al.  Enhancement in therapeutic efficacy of miltefosine in combination with synthetic bacterial lipopeptide, Pam3Cys against experimental Visceral Leishmaniasis. , 2012, Experimental parasitology.

[7]  E. De Gregorio,et al.  MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action , 2012, The Journal of Immunology.

[8]  D. Filippov,et al.  TLR ligand-peptide conjugate vaccines: toward clinical application. , 2012, Advances in immunology.

[9]  C. Bertozzi,et al.  From Mechanism to Mouse: A Tale of Two Bioorthogonal Reactions , 2011, Accounts of chemical research.

[10]  P. Friedl,et al.  Readily Accessible Bicyclononynes for Bioorthogonal Labeling and Three-Dimensional Imaging of Living Cells , 2010, Angewandte Chemie.

[11]  S. H. van der Burg,et al.  Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells. , 2009, Molecular immunology.

[12]  M. J. Uddin,et al.  Synthesis of 5- and 6-Carboxy-X-rhodamines , 2008, Organic letters.

[13]  S. Paik,et al.  Crystal Structure of the TLR1-TLR2 Heterodimer Induced by Binding of a Tri-Acylated Lipopeptide , 2007, Cell.

[14]  S. H. van der Burg,et al.  Distinct Uptake Mechanisms but Similar Intracellular Processing of Two Different Toll-like Receptor Ligand-Peptide Conjugates in Dendritic Cells* , 2007, Journal of Biological Chemistry.

[15]  S. H. van der Burg,et al.  Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonists. , 2007, Vaccine.

[16]  D. Busch,et al.  Protective CD8 T Cell Immunity Triggered by CpG-Protein Conjugates Competes with the Efficacy of Live Vaccines1 , 2005, The Journal of Immunology.

[17]  Corey Smith,et al.  A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G. Jung,et al.  Synthetic lipopeptide adjuvants and Toll-like receptor 2--structure-activity relationships. , 2004, Vaccine.

[19]  R. Vabulas,et al.  CpG‐DNA aided cross‐presentation of soluble antigens by dendritic cells , 2002, European journal of immunology.

[20]  E. Raz,et al.  Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. , 2000, The Journal of allergy and clinical immunology.

[21]  Jing Zhang,et al.  Disulfide bond formation in peptides by dimethyl sulfoxide. Scope and applications , 1991 .

[22]  W. Bessler,et al.  Lipopeptides containing 2-(palmitoylamino)-6,7-bis(palmitoyloxy) heptanoic acid: synthesis, stereospecific stimulation of B-lymphocytes and macrophages, and adjuvanticity in vivo and in vitro. , 1991, Journal of medicinal chemistry.

[23]  V. Braun,et al.  Covalent lipoprotein from the outer membrane of Escherichia coli. , 1975, Biochimica et biophysica acta.